Hosted on MSN1mon
NAMSA acquires WuXi AppTec’s US medical device testing facilities
Contract research organisation (CRO) NAMSA has acquired the US-based medical device testing operations of WuXi AppTec to strengthen its medtech clinical research testing capabilities. The deal ...
Morningstar22d
Brian P. Smith Joins NAMSA as Chief Executive Officer; Brings 15+ Years of Life Sciences Leadership Expertise to Role
TOLEDO, Ohio, Feb. 24, 2025 /PRNewswire/ -- NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announced today that Brian P. Smith has taken on the role of NAMSA's ...
Longview News-Journal15d
NAMSA Completes Acquisition of WuXi AppTec US Medical Device Testing Business
TOLEDO, Ohio, March 3, 2025 /PRNewswire/ -- NAMSA, a leading US based MedTech testing, clinical and regulatory consulting firm, announced that it finalized its acquisition of WuXi AppTec's US ...
Yahoo Finance1mon
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures
We are very pleased to be working with NAMSA and leveraging their vascular clinical and regulatory expertise to execute this important study as efficiently as possible.” Dr Adam Saltman ...